![]() |
|
|
Vol. 304, Issue 1, 22-29, January 2003
National Heart and Lung Institute, Imperial College School of
Science, Technology and Medicine, London, United Kingdom (P.R.E., N.P.,
M.S., P.N., S.-Y.L., K.F.C.); Department of Pediatric Pneumology and
Immunology, Charite-Virchow Klinikum, Humboldt-University, Berlin,
Germany (D.A.G.); and Department of Immunology, Kings College School of
Medicine, London, United Kingdom (A.N.)
Chronic cellular inflammation and airway wall remodeling with
subepithelial fibrosis and airway smooth muscle thickening are features
of chronic asthma. We determined the role of nitric oxide in the
pathogenesis of allergen-induced airway cell proliferation and
inflammation by studying the effects of a relatively selective prodrug
inhibitor of nitric-oxide synthase type 2 (NOS2),
L-N6-(1-iminoethyl)-lysine-5-tetrazole
amide (SC-51). Brown-Norway rats were sensitized to ovalbumin and were
exposed to ovalbumin aerosol every 3rd day on six occasions and were
treated orally with either vehicle or SC-51 (10 mg · kg
1; 12 doses). We measured inflammatory cell
accumulation in the airways and proliferation of cells by incorporation
of bromodeoxyuridine. There was an increase in the total number of
airway smooth muscle cells expressing bromodeoxyuridine from 1.3% of
airway smooth muscle cells in saline exposed to 5.4% after
allergen-exposure (P < 0.001) and airway
epithelial cells from 3.3 cells/mm basement membrane to 9.6 after
allergen-exposure (P < 0.001). SC-51 had no effect
on airway smooth muscle or epithelial cell proliferation. SC-51
attenuated the allergen-induced increase in major basic protein (MBP+)
eosinophil (P < 0.05) and CD4+ T-cell
(P < 0.05) accumulation. We conclude that nitric
oxide derived during allergic inflammation is involved in the
expression of eosinophilic inflammation and not in epithelial or airway
smooth muscle cell DNA synthesis induced by chronic allergen exposure.
This article has been cited by other articles:
![]() |
C. M. Prado, E. A. Leick-Maldonado, L. Yano, A. S. Leme, V. L. Capelozzi, M. A. Martins, and I. F. L. C. Tiberio Effects of Nitric Oxide Synthases in Chronic Allergic Airway Inflammation and Remodeling Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 457 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hjoberg, S. Shore, L. Kobzik, S. Okinaga, A. Hallock, J. Vallone, V. Subramaniam, G. T. De Sanctis, J. A. Elias, J. M. Drazen, et al. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness J Appl Physiol, July 1, 2004; 97(1): 249 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260. [Abstract] [Full Text] [PDF] |
||||